Matilde Mori
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 15
- COVID-19 Clinical Research Studies 2
- Infection Control in Healthcare 1
-
- COVID-19 epidemiological studies 3
- Co-authors
- Nathan A. Moore (2 shared papers)Jessica L. Lynch (2 shared papers)Gabrielle Vernet (2 shared papers)Rebecca J. Williams (2 shared papers)Kordo B. A. Saeed (2 shared papers)Stephen P. Kidd (1 shared paper)Pete Philipson (1 shared paper)Nicholas Cortes (1 shared paper)
- Journals
- Nature (3 papers)Scientific Reports (2 papers)Nature Communications (2 papers)BMC Infectious Diseases (1 paper)iScience (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Matilde Mori
18 papers receiving 3.7k citations
Matilde Mori's Hit Papers
Peers
Comparison fields: 5 of 104
- Infectious Diseases 3.3k
- Modeling and Simulation 217
- Genetics 116
- Neurology 48
- Molecular Biology 196
Countries citing papers authored by Matilde Mori
This map shows the geographic impact of Matilde Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matilde Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matilde Mori more than expected).
Fields of papers citing papers by Matilde Mori
This network shows the impact of papers produced by Matilde Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matilde Mori. The network helps show where Matilde Mori may publish in the future.
Co-authors
The 19 scholars most cited alongside Matilde Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 2 | 2020 | 756 | |
| 3 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 571 |
| 4 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 5 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 6 | 2021 | 273 | |
| 7 | 2021 | 228 | |
| 8 | 2021 | 72 | |
| 9 | 2021 | 68 | |
| 10 | 2022 | 45 | |
| 11 | 2022 | 31 | |
| 12 | 2022 | 17 | |
| 13 | 2022 | 15 | |
| 14 | 2022 | 13 | |
| 15 | 2021 | 11 | |
| 16 | 2022 | 8 | |
| 17 | HLA-B*58:02-specific benefit of MRKAd5 Gag/Pol/Nef vaccine in an African population | 2015 | 1 |
| 18 | 2023 | 1 |
About Matilde Mori
Matilde Mori is a scholar working on Infectious Diseases, Modeling and Simulation, Virology, Epidemiology and Molecular Biology, having authored 18 papers that have together received 3.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 epidemiological studies (3 papers), COVID-19 Clinical Research Studies (2 papers), Infection Control in Healthcare (1 paper), HIV Research and Treatment (1 paper), Sepsis Diagnosis and Treatment (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Infectious Diseases (3.3k citations), Modeling and Simulation (217 citations), Genetics (116 citations), Neurology (48 citations) and Molecular Biology (196 citations). Matilde Mori has collaborated with scholars based in United Kingdom. Frequent co-authors include Nathan A. Moore, Jessica L. Lynch, Gabrielle Vernet, Rebecca J. Williams, Kordo B. A. Saeed, Stephen P. Kidd, Pete Philipson, Nicholas Cortes, Michelle Young and Gabriele Pollara. Their work appears in journals such as Nature, Scientific Reports, Nature Communications, BMC Infectious Diseases and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.